Sorrento Therapeutics (SRNE)
(Delayed Data from OTC)
$0.00 USD
0.00 (-25.00%)
Updated Sep 13, 2024 03:56 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For SRNE
-
Sorrento Therapeutics: Q3 Earnings Snapshot
-
Analysts Estimate Sorrento Therapeutics (SRNE) to Report a Decline in Earnings: What to Look Out for
-
Will Sorrento Therapeutics (SRNE) Report Negative Q3 Earnings? What You Should Know
-
Sorrento (SRNE) to Report Q2 Earnings: What's in the Cards?
-
Will Sorrento Therapeutics (SRNE) Report Negative Q2 Earnings? What You Should Know
-
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Sorrento (SRNE) to Report Q4 Earnings: What's in the Cards?
-
Will Sorrento Therapeutics (SRNE) Report Negative Q3 Earnings? What You Should Know
-
Sorrento (SRNE) to Report Q3 Earnings: What's in the Cards?
-
Will Sorrento Therapeutics (SRNE) Report Negative Q2 Earnings? What You Should Know
-
Sorrento (SRNE) to Report Q2 Earnings: What's in the Cards?
-
Earnings Estimates Moving Higher for Sorrento Therapeutics (SRNE): Time to Buy?
-
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Earnings Preview: Sorrento Therapeutics (SRNE) Q4 Earnings Expected to Decline
-
Earnings Preview: Sorrento Therapeutics (SRNE) Q3 Earnings Expected to Decline
-
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
What's in Store for Sorrento (SRNE) This Earnings Season?
-
Analysts Estimate Sorrento Therapeutics (SRNE) to Report a Decline in Earnings: What to Look Out for